The administration of an IL-17A neutralizing antibody in an Aβ-injection mediated AD mouse model ameliorates cognitive impairment and neuroinflammation, underscoring the functional significance of IL-17A in AD pathogenesis (Cristiano et al. 2019). Here, IL17A is linked to Cognitive impairment.